M 144
Pill imprint M 144 has been identified as Tamoxifen citrate 10 mg.
Tamoxifen is used in the treatment of breast cancer; breast cancer, metastatic; precocious puberty; breast cancer, adjuvant; breast cancer, male (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy.
Tamoxifen 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Tamoxifen citrate Images
- Imprint:
-
M
144 - Strength:
- 10 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
crospovidone
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
- Drug Class:
- Hormones/antineoplastics
Selective estrogen receptor modulators - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0144
Advertisement
More Tamoxifen Citrate resources
- Tamoxifen
- Tamoxifen (Wolters Kluwer)
- Tamoxifen Solution (Wolters Kluwer)
- tamoxifen (Cerner Multum)
- tamoxifen (Micromedex) - Includes Dosage Information
- Tamoxifen Citrate (AHFS DI)
- Tamoxifen (FDA)
- Tamoxifen Citrate (Wolters Kluwer)
Search Again
